Traders sold shares of HCA Healthcare Inc (NYSE:HCA) on strength during trading on Tuesday. $46.75 million flowed into the stock on the tick-up and $119.65 million flowed out of the stock on the tick-down, for a money net flow of $72.90 million out of the stock. Of all equities tracked, HCA Healthcare had the 33rd highest net out-flow for the day. HCA Healthcare traded up $2.99 for the day and closed at $128.88
A number of research analysts have weighed in on the company. Zacks Investment Research downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Thursday, December 20th. ValuEngine cut HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, March 6th. Finally, UBS Group started coverage on HCA Healthcare in a research report on Thursday, November 15th. They issued a “buy” rating and a $162.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and seventeen have given a buy rating to the company’s stock. HCA Healthcare has a consensus rating of “Buy” and a consensus target price of $148.43.
The stock has a market capitalization of $44.16 billion, a P/E ratio of 13.49, a PEG ratio of 1.07 and a beta of 0.80.
The firm also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Investors of record on Friday, March 1st will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, February 28th. This represents a $1.60 annualized dividend and a dividend yield of 1.21%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.35. HCA Healthcare’s dividend payout ratio (DPR) is currently 16.38%.
In related news, SVP Deborah M. Reiner sold 466 shares of the stock in a transaction dated Tuesday, February 5th. The stock was sold at an average price of $139.07, for a total transaction of $64,806.62. Following the completion of the sale, the senior vice president now owns 5,037 shares in the company, valued at $700,495.59. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Bill B. Rutherford sold 37,500 shares of the stock in a transaction dated Tuesday, February 12th. The stock was sold at an average price of $139.65, for a total value of $5,236,875.00. Following the sale, the chief financial officer now owns 58,972 shares of the company’s stock, valued at approximately $8,235,439.80. The disclosure for this sale can be found here. Insiders have sold 78,476 shares of company stock valued at $10,940,008 in the last quarter. 2.80% of the stock is currently owned by company insiders.
Several large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in shares of HCA Healthcare by 0.3% during the third quarter. Vanguard Group Inc. now owns 19,916,360 shares of the company’s stock worth $2,770,765,000 after purchasing an additional 66,808 shares in the last quarter. Vanguard Group Inc boosted its stake in HCA Healthcare by 0.3% during the third quarter. Vanguard Group Inc now owns 19,916,360 shares of the company’s stock valued at $2,770,765,000 after buying an additional 66,808 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its stake in HCA Healthcare by 16,494.3% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 11,119,359 shares of the company’s stock valued at $89,000 after buying an additional 11,052,352 shares during the last quarter. FMR LLC boosted its stake in HCA Healthcare by 98.7% during the third quarter. FMR LLC now owns 10,907,407 shares of the company’s stock valued at $1,517,438,000 after buying an additional 5,419,134 shares during the last quarter. Finally, Lyrical Asset Management LP boosted its stake in HCA Healthcare by 2.0% during the third quarter. Lyrical Asset Management LP now owns 4,078,212 shares of the company’s stock valued at $567,361,000 after buying an additional 80,081 shares during the last quarter. Hedge funds and other institutional investors own 70.29% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Traders Sell HCA Healthcare (HCA) on Strength (HCA)” was first posted by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.themarketsdaily.com/2019/03/15/traders-sell-hca-healthcare-hca-on-strength-hca.html.
HCA Healthcare Company Profile (NYSE:HCA)
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.